We are live on
!
Find out more
SP
Steelhead Partners Portfolio holdings
AUM
$1.39B
1-Year Est. Return
0.01%
This Fund
S&P 500
This Quarter
Est. Return
0%
1 Year Est. Return
+0.01%
3 Year Est. Return
+0.04%
5 Year Est. Return
+0.04%
10 Year Est. Return
+4.69%
AUM
$1.37B
AUM Growth
+$22.1M
(+1.6%)
Cap. Flow
-$1.15B
Cap. Flow
% of AUM
-83.46%
Top 10 Holdings %
Top 10 Hldgs %
42.25%
Holding
42
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$721K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0% |
Similar funds
HRES
SRAIM
PMG
TCC
SC
BCP
TA
OCM
Steelhead Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Steelhead Partners held 42 positions worth $1.37B, up 1.6% from $1.35B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Steelhead Partners withdrew a net $1.15B in Q4 2022, closing 1 position. Its most notable exit was Alnylam Pharmaceuticals, an estimated $721K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 0% of assets, down from 0.05% a quarter earlier.
- Steelhead Partners fully exited Alnylam Pharmaceuticals in Q4 2022, selling an estimated $721K.
- Steelhead Partners's ten largest holdings make up 42% of its $1.37B portfolio in Q4 2022.
- Steelhead Partners opened 0 new positions and closed 1 in Q4 2022.
- Steelhead Partners's portfolio value rose 1.6% quarter-over-quarter to $1.37B.
Based on Steelhead Partners's 13F filing for Q4 2022, filed 14 Feb 2023.